Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “Lauren is smart, professional in word and manner, and quite intuitive in analyzing situations. She thinks through and researches issues before proposing solutions. One of her best qualities is that of keeping her client(s) focused on the defined goals for settling the problems at hand using her cheerful personality.  It is indeed a pleasure working with Lauren."

    -Claire Johnson

  • “For the past four years, my Atlantic Capital Bank deal team has engaged the legal services of Lindsey Arnold to close several large and complex bank loan transactions.  To name a few, these deals include a $10million line of credit to a linen service company, a $15million Term Loan to a prominent, market leading textile manufacturer (and a subsequent recapitalization of this loan arrangement), a $12million Term Loan facility for a major grocery store chain, a $12million Construction to Mini Perm Facility and a separate $10million for a large national beverage distribution family of businesses.  Not only was Lindsey’s service of the utmost professionalism and very quick responsiveness, but also she treated the bank’s client’s with a very high level of courteousness and integrity.  Our clients are the lifeblood of our business and it is important that our legal partners handle our relationships get off to a good start.  In addition, rarely do loans sit on a shelf…there are always changes along the way and Lindsey has been very quick to respond to our needs (driven by our clients’ needs) in terms of amendments and deal restructurings.  In addition to solid deal execution…Lindsey is a terrific resource when it comes to early stage legal guidance as we as bankers think through competitive and creative deal structures.  Lindsey has been great and we hope to steer more deals in her direction as we grow the institution.”

    -Sandy Bowen, Atlantic Capital Bank

  • "Quality is the thing that comes through so clearly- these lawyers not only raise the issues as they find them, but do so in a constructive way. Alternatives are always provided, with complete knowledge available with each. Sound, workable compromises are often reached simply and quickly, keeping the proper balance between us and our clients. They perform excellence top-to-bottom. bright, hard-working attorneys are hired and brought along thoughtfully by the more senior partners, producing very effective and efficient practice having a great deal of consistency. Their well-staffed and well-trained team has always been a hallmark."

    -Chambers 2012

  • “Michael did work for us while I was CEO at Guided Therapeutics and after spending literally millions on patent work, I have to say that Michael is one of the best IP attorneys that I have ever worked with. I highly recommend him. Almost any attorney can get a patent issued, however the real trick is to get a patent issued that has real value and can stand against litigation. Michael is also especially knowledgeable in foreign IP rights and is very cost effective.”

    -Mark Samuels, CEO, Guided Therapeutics, medical device manufacturer

  • “I think a lot of him. He is reasonable and logical. He is very good at getting the deal done and doing so in a collaborative way as opposed to adversarial. I always refer to him and believe he will take care of the client.”

    -Chambers 2012